This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Andrew Beaton and His Patent Work
Introduction
Andrew Beaton is an inventor associated with Collegeville, Pennsylvania, United States. The information provided identifies him as a named inventor on 1 patent and connects his work with GlaxoSmithKline Intellectual Property Development Limited.
Latest Patents
Beaton’s listed patent is “IL-33 Binding Antibodies.” The title indicates that the invention concerns antibodies that bind to IL-33.
Career Highlights
The available information highlights Beaton’s patent contribution in the area of IL-33-binding antibodies. His listed company affiliation is GlaxoSmithKline Intellectual Property Development Limited.
Collaborations
Beaton’s listed coworkers include Martin Orecchia and Matthew Edwards.
Conclusion
Andrew Beaton’s recorded patent work centers on IL-33-binding antibodies and reflects his association with GlaxoSmithKline Intellectual Property Development Limited.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile